Skip to main content
. 2018 Jun 1;13(6):e0198285. doi: 10.1371/journal.pone.0198285

Table 1. Patient characteristics.

ESRD (N = 118) ESRD or CrCl <30 ml/min and no dialysis (N = 590) CrCl ≥30 ml/min (N = 3089)
Demographics
Age, mean (SD) 62.6 (14.1) 68.6 (14.6) 60.1 (16.5)
Female, N (%) 46 (39.0) 270 (45.8) 1320 (42.7)
APACHE II score, mean (SD) 27.3 (7.4) 26.9 (7.3) 20.5 (7.4)
BMI, mean (SD) 28.1 (7.5) 27.3 (6.7) 28.5 (7.9)
Medical admission, N (%) 94 (79.7) 449 (76.1) 2327 (75.3)
Personal history of VTE, N (%) 8 (6.8) 20 (3.4) 99 (3.2)
Family history of VTE, N (%) 1 (0.8) 5 (0.8) 51 (1.7)
History of malignancy, N (%) 5 (4.2) 21 (3.6) 126 (4.1)
Admitting diagnosis, N (%)
Cardiovascular 14 (11.9) 65 (11.0) 266 (8.6)
Respiratory 31 (26.3) 179 (30.3) 1496 (48.4)
Gastrointestinal 9 (7.6) 86 (14.6) 430 (13.9)
Renal 13 (11.0) 45 (7.6) 20 (0.6)
Neurologic 8 (6.8) 17 (2.9) 205 (6.6)
Sepsis 31 (26.3) 151 (25.6) 398 (12.9)
Metabolic 2 (1.7) 20 (3.4) 122 (3.9)
Other–medical 2 (1.7) 9 (1.5) 54 (1.7)
Other–surgical 8 (6.8) 18 (3.1) 98 (3.2)
Life support, N (%)
Mechanical ventilation 94 (80.3) 513 (87.1) 2808 (90.9)
Vasopressors 57 (48.7) 349 (59.3) 1305 (42.2)
Central venous catheterization 108 (92.3) 548 (93.0) 2483 (80.4)